Oncolytics Biotech Inc (ONCY) Hedge Fund Ownership (Q2 2026)

Q: Is it too late to buy Oncolytics Biotech Inc (ONCY) following the 2026 Q2 hedge fund 13F filings?

As of today, ONCY has moved -19.3% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.4% for the XLV sector ETF — an outperformance of -19.7%. Since the quarter end (June 30, 2026), ONCY gained -29.5% vs +5.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Oncolytics Biotech Inc (ONCY)

1 + Investors. Track Smart Money conviction in ONCY. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ONCY

Based on 78 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds added ONCY than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

78 hedge funds hold ONCY right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +42% more funds vs a year ago

fund count last 6Q

+23 new funds entered over the past year (+42% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 70% buying

42 buying18 selling

Last quarter: 42 funds were net buyers (29 opened a brand new position + 13 added to an existing one). Only 18 were sellers (9 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+15 vs last Q)

new funds entering per quarter

Funds opening a new ONCY position: 9 → 13 → 14 → 29. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔒

41% of holders stayed for 2+ years

■ 41% conviction (2yr+) ■ 24% medium ■ 35% new

32 out of 78 hedge funds have held ONCY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

🚀

Acceleration phase — new buyers rushing in

11 → 9 → 13 → 14 → 29 new funds/Q

New funds entering each quarter: 9 → 13 → 14 → 29. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Veteran-anchored — 46% veterans vs 42% newcomers

■ 46% veterans ■ 12% 1-2yr ■ 42% new

Entry-cohort mix of 78 holders: 36 (46%) are 2+ year veterans, 9 entered 1–2 years ago, and 33 (42%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

✅

Strong quality — 20% AUM from major funds

20% from top-100 AUM funds

21 of 78 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

4.2

out of 10

Moderate Exit Risk

Exit risk score 4.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	1	56	-98.21%
13F Shares	13K	3M	-99.56%
Total Value	$13K	$3M	-99.5%
New Positions	1	14	-13
Increased Positions	0	16	-16
Closed Positions	56	19	+37
Reduced Positions	0	3	-3
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

-98.21%

13F Shares

13K

-99.56%

Total Value

$13K

$3M

-99.5%

New Positions

-13

Increased Positions

-16

Closed Positions

+37

Reduced Positions

-3

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q2)

1 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ONCY. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ONCY holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Connective Capital Management, LLC	0.12%	185,712	$176K
2	Seeds Investor LLC	0.03%	258,306	$245K
3	Doliver Advisors, LP	0.02%	100,000	$95K
4	Security National Bank of Sioux City Iowa /Ia/	0.01%	33,255	$32K
5	International Assets Investment Management, LLC	0.01%	201,260	$181K
6	Vantage Point Financial LLC	0.01%	29,744	$28K
7	Everhart Financial Group, Inc.	0.01%	140,899	$134K
8	Headinvest, LLC	0.01%	44,700	$42K
9	PFG Investments, LLC	0.00%	128,300	$122K
10	XTX Topco Ltd	0.00%	260,903	$248K
11	Tocqueville Asset Management L.P.	0.00%	147,000	$140K
12	Catalyst Funds Management Pty Ltd	0.00%	31,676	$30K
13	Valley National Advisers Inc	0.00%	12,000	$11K
14	Two Sigma Securities, LLC	0.00%	14,862	$14K
15	Cedar Mountain Advisors, LLC	0.00%	5,651	$5K
16	Activest Wealth Management	0.00%	5,000	$5K
17	Badgley Phelps Wealth Managers, LLC	0.00%	40,000	$38K
18	Marshall Wace, LLP	0.00%	745,350	$708K
19	Ausdal Financial Partners, Inc.	0.00%	12,000	$11K
20	Clearstead Advisors, LLC	0.00%	39,000	$37K
21	Y-Intercept (Hong Kong) Ltd	0.00%	13,290	$13K
22	AlphaCore Capital LLC	0.00%	12,500	$12K
23	Hrt Financial LP	0.00%	126,325	$119K
24	Crestwood Advisors Group, LLC	0.00%	10,000	$9K
25	Kingsview Wealth Management, LLC	0.00%	11,210	$11K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Oncolytics Biotech Inc (ONCY)

What does the Smart Money Trend signal show for ONCY?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ONCY than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ONCY?

More buyers than sellers — 70% buying: Last quarter: 42 funds were net buyers (29 opened a brand new position + 13 added to an existing one). Only 18 were sellers (9 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ONCY holders?

Strong quality — 20% AUM from major funds: 21 of 78 holders rank in the top 100 by AUM, accounting for 20% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ONCY?

41% of holders stayed for 2+ years: 32 out of 78 hedge funds have held ONCY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Oncolytics Biotech Inc (ONCY) following the 2026 Q2 hedge fund 13F filings?

As of today, ONCY has moved -19.3% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.4% for the XLV sector ETF — an outperformance of -19.7%. Since the quarter end (June 30, 2026), ONCY has gained -29.5% vs +5.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Oncolytics Biotech Inc (ONCY)

Smart Money Signals — ONCY

Buying streak — 1 quarter in a row

At the ownership peak (100% of max)

Fast accumulation — +42% more funds vs a year ago

More buyers than sellers — 70% buying

More new buyers each quarter (+15 vs last Q)

41% of holders stayed for 2+ years

Acceleration phase — new buyers rushing in

Veteran-anchored — 46% veterans vs 42% newcomers

Strong quality — 20% AUM from major funds

Institutional Sentiment Summary — ONCY

Hedge Fund Ownership: ONCY

Market Analysis: ONCY

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ONCY

Is It Too Late to Buy Oncolytics Biotech Inc (ONCY) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: ONCY

Statistics: ONCY

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Oncolytics Biotech Inc (ONCY)

Welcome to 13Foresight!